Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BRAVE BISON GROUP PLC Director's Dealing 2018

Dec 10, 2018

7530_mrq_2018-12-10_a0874457-794c-4e5a-ac88-98280b636120.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0070K

Brave Bison Group PLC

10 December 2018

10 December 2018

Brave Bison Group plc

("Brave Bison" or the "Company")

Holding(s) in Company

Brave Bison announces that is has been advised today by Simon Davies that, following recent share purchases, he is now directly and indirectly interested in 23,366,559 ordinary shares in the Company, representing 4.06 per cent. of the voting rights in the Company.

-ENDS-

For further information, contact: 

Brave Bison Group Tel: 020 7183 4545
Claire Hungate, Chief Executive Officer
Allenby Capital Limited Tel: 020 3328 5656
Jeremy Porter / Asha Chotai
Newgate Communications Tel: 020 3757 6880
Elisabeth Cowell / Robin Tozer / Fiona Norman [email protected]

About Brave Bison:

Brave Bison is a social video company, proudly working with some of the biggest brands and most followed YouTube and Facebook talent in the world. Clients include P&G, Shell, PUMA and Hyundai. 

Brave Bison makes it simple for content owners, creators, brands, publishers and platforms to unlock the value of online video, whether on a licensed, ad-funded, direct to consumer or paid placement basis. 

The business is based in two regions - Europe, with headquarters in London; and APAC, with offices in Singapore.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

HOLTMBITMBIBBRP